Resources with keywords: chikungunya
Cerqueira-Silva T, et al
Chikungunya virus disease is associated with an increased risk of death for up to 84 days after symptom onset, including deaths from cerebrovascular diseases, ischaemic heart diseases, and diabetes.
From FDA’s Release: Ixchiq is administered as a single dose by injection into the muscle. It contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.
Reference document on Chikungunya Virus
This chapter includes information on the agent, transmission, diagnosis, treatment, prevention, epidemiology